[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 6ct7 Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models. |
Resolution | 1.903 Å |
Binding residue (original residue number in PDB) | L27 M29 Q30 F31 H33 Y48 K49 D50 |
Binding residue (residue number reindexed from 1) | L27 M29 Q30 F31 H33 Y48 K49 D50 |
|